LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 10 of total 185

Search options

  1. Book: The urinary tract

    Hansel, Donna E.

    a comprehensive guide to patient diagnosis and management

    2012  

    Author's details Donna E. Hansel
    Language English
    Size XVI, 354 S., zahlr. Ill., graph. Darst.
    Publisher Springer
    Publishing place New York u.a.
    Publishing country United States
    Document type Book
    HBZ-ID HT017516079
    ISBN 978-1-4614-5319-2 ; 1-4614-5319-4 ; 9781461453208 ; 1461453208
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  2. Book ; Online ; E-Book: Precision molecular pathology of bladder cancer

    Hansel, Donna E. / Lerner, Seth P.

    (Molecular pathology library)

    2018  

    Author's details Donna E. Hansel, Seth P. Lerner editors
    Series title Molecular pathology library
    Keywords Medicine ; Oncology ; Pathology ; Urology
    Subject code 616.07
    Language English
    Size 1 Online-Ressource (IX, 243 Seiten)
    Publisher Springer
    Publishing place Cham
    Publishing country Switzerland
    Document type Book ; Online ; E-Book
    Remark Zugriff für angemeldete ZB MED-Nutzerinnen und -Nutzer
    HBZ-ID HT019615505
    ISBN 978-3-319-64769-2 ; 9783319647678 ; 3-319-64769-5 ; 3319647679
    DOI 10.1007/978-3-319-64769-2
    Database ZB MED Catalogue: Medicine, Health, Nutrition, Environment, Agriculture

    Kategorien

  3. Article ; Online: A 25 year perspective on advances in the pathologic assessment and diagnosis of urologic cancers.

    Hansel, Donna E

    Urologic oncology

    2021  Volume 39, Issue 9, Page(s) 582–594

    Abstract: Over the past 25 years, diagnostic categories in genitourinary pathology have changed dramatically. Prostate cancer reporting incorporated numerous new variant categories, recognized the importance of intraductal carcinoma, and introduced the concept of ... ...

    Abstract Over the past 25 years, diagnostic categories in genitourinary pathology have changed dramatically. Prostate cancer reporting incorporated numerous new variant categories, recognized the importance of intraductal carcinoma, and introduced the concept of Grade Groups. Pathologic diagnosis of bladder cancer not only added new variant categories, but also modified the grading of non-invasive urothelial neoplasms and refined staging definitions. Kidney cancer classification expanded from a handful of diagnostic categories to a broad array of additional cancer types defined by unique immunohistochemical and molecular findings. Segregation of penile carcinoma by human papillomavirus status more accurately reflected pathogenesis and helped improve prediction of cancer behavior. Testicular pathology research advanced understanding of germ cell tumor subtypes and their impact on patient outcomes. Finally, adrenal gland pathology has evolved to incorporate a broader recognition of morphological variation and risk factors associated with tumor progression. Taken together, changes in pathology over the past quarter century have revolutionized our approach to genitourinary cancers. This review seeks to highlight some of the many significant changes in genitourinary pathology that have occurred during the past 25 years and emphasize impacts on clinical outcomes or therapy, as relevant.
    MeSH term(s) History, 20th Century ; History, 21st Century ; Humans ; Male ; Time Factors ; Urologic Neoplasms/diagnosis ; Urologic Neoplasms/history ; Urologic Neoplasms/pathology
    Language English
    Publishing date 2021-06-30
    Publishing country United States
    Document type Historical Article ; Journal Article ; Review
    ZDB-ID 1336505-8
    ISSN 1873-2496 ; 1078-1439
    ISSN (online) 1873-2496
    ISSN 1078-1439
    DOI 10.1016/j.urolonc.2021.05.016
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Book: The kidney

    Hansel, Donna E. / Kane, Christopher J. / Paner, Gladell P. / Chang, Sam S.

    a comprehensive guide to pathologic diagnosis and management

    2016  

    Author's details Donna E. Hansel, Christopher J. Kane, Gladell P. Paner, Sam S. Chang editors
    Keywords Kidneys/Surgery ; Kidneys/Diseases/Diagnosis ; Kidneys/Diseases/Treatment
    Subject code 617.461
    Language English
    Size ix, 215 Seiten, Illustrationen, Diagramme, 26 cm
    Publisher Springer
    Publishing place New York
    Publishing country United States
    Document type Book
    HBZ-ID HT018862632
    ISBN 978-1-4939-3285-6 ; 978-1-4939-3286-3 ; 1-4939-3285-3 ; 1-4939-3286-1
    Database Catalogue ZB MED Medicine, Health

    More links

    Kategorien

  5. Article ; Online: The Many Faces of Muscle-Invasive Bladder Cancer: Histopathological and Molecular Characterization.

    Mau, Brian / Johnson, Burles / Hansel, Donna E / McConkey, David J

    Seminars in radiation oncology

    2022  Volume 33, Issue 1, Page(s) 1–11

    MeSH term(s) Humans ; Urinary Bladder Neoplasms/genetics ; Muscles/pathology ; Neoplasm Invasiveness
    Language English
    Publishing date 2022-12-11
    Publishing country United States
    Document type Journal Article ; Review
    ZDB-ID 1146999-7
    ISSN 1532-9461 ; 1053-4296
    ISSN (online) 1532-9461
    ISSN 1053-4296
    DOI 10.1016/j.semradonc.2022.10.001
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: The Gleason Grading System: The Approach that Changed Prostate Cancer Assessment.

    Hansel, Donna E

    The Journal of urology

    2016  Volume 197, Issue 2S, Page(s) S140–S141

    MeSH term(s) Adenocarcinoma ; Humans ; Male ; Neoplasm Grading ; Prognosis ; Prostatic Neoplasms
    Language English
    Publishing date 2016-12-20
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 3176-8
    ISSN 1527-3792 ; 0022-5347
    ISSN (online) 1527-3792
    ISSN 0022-5347
    DOI 10.1016/j.juro.2016.11.028
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. Article ; Online: Expression of uroplakin II and GATA-3 in bladder cancer mimickers: caveats in the use of a limited panel to determine cell of origin in bladder lesions.

    Leivo, Mariah Z / Tacha, David E / Hansel, Donna E

    Human pathology

    2021  Volume 113, Page(s) 28–33

    Abstract: Antibodies targeting uroplakin II (UPII) are highly specific for urothelial cells and are frequently used to determine if a primary bladder lesion or a metastatic lesion originates from the urothelium. However, to date, no studies have tested the ... ...

    Abstract Antibodies targeting uroplakin II (UPII) are highly specific for urothelial cells and are frequently used to determine if a primary bladder lesion or a metastatic lesion originates from the urothelium. However, to date, no studies have tested the expression of UPII in histological mimickers of bladder cancer that are nonurothelial in origin. Given the potential risk of misdiagnosis, immunohistochemical markers are often used to better characterize these lesions. In the present study, we analyzed the immunohistochemical expression of UPII in a set of urothelial carcinoma mimickers that included conventional nephrogenic adenoma (n = 8), papillary nephrogenic adenoma (n = 6), endometriosis/endosalpingiosis (n = 5), inflammatory myofibroblastic tumor (n = 4), ectopic prostate tissue (n = 2), and malakoplakia (n = 2). We also examined the expression of GATA-3, another commonly used immunohistochemical marker in bladder cancer diagnosis, in the same lesions. Weak immunoreactivity for UPII was identified in 6 of 27 mimickers (22%), and GATA-3 was expressed in 16 of 27 mimickers (59%). Strong immunoreactivity for UPII appeared to be a specific marker for urothelial cell of origin, although weak staining was seen in a significant proportion of mimickers. GATA-3 immunostaining was present in a greater number and broader spectrum of mimickers; however, only one case of papillary nephrogenic adenoma showed dual positivity for UPII and GATA-3. These findings support the immunohistochemical panel-based approach in the diagnosis of bladder lesions, especially if nonurothelial bladder cancer mimickers are in the differential diagnosis. Additional larger studies would be of value to expand on these findings.
    MeSH term(s) Aged ; Biomarkers, Tumor/analysis ; Diagnosis, Differential ; Female ; GABA Plasma Membrane Transport Proteins/analysis ; Humans ; Immunohistochemistry ; Male ; Middle Aged ; Predictive Value of Tests ; Reproducibility of Results ; Urinary Bladder Neoplasms/chemistry ; Urinary Bladder Neoplasms/pathology ; Uroplakin II/analysis
    Chemical Substances Biomarkers, Tumor ; GABA Plasma Membrane Transport Proteins ; SLC6A11 protein, human ; UPK2 protein, human ; Uroplakin II
    Language English
    Publishing date 2021-04-19
    Publishing country United States
    Document type Comparative Study ; Journal Article
    ZDB-ID 207657-3
    ISSN 1532-8392 ; 0046-8177
    ISSN (online) 1532-8392
    ISSN 0046-8177
    DOI 10.1016/j.humpath.2021.04.005
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  8. Article: Emerging Roles for Mammalian Target of Rapamycin (mTOR) Complexes in Bladder Cancer Progression and Therapy.

    Huan, Jianya / Grivas, Petros / Birch, Jasmine / Hansel, Donna E

    Cancers

    2022  Volume 14, Issue 6

    Abstract: The mammalian target of rapamycin (mTOR) pathway regulates important cellular functions. Aberrant activation of this pathway, either through upstream activation by growth factors, loss of inhibitory controls, or molecular alterations, can enhance cancer ... ...

    Abstract The mammalian target of rapamycin (mTOR) pathway regulates important cellular functions. Aberrant activation of this pathway, either through upstream activation by growth factors, loss of inhibitory controls, or molecular alterations, can enhance cancer growth and progression. Bladder cancer shows high levels of mTOR activity in approximately 70% of urothelial carcinomas, suggesting a key role for this pathway in this cancer. mTOR signaling initiates through upstream activation of phosphatidylinositol 3 kinase (PI3K) and protein kinase B (AKT) and results in activation of either mTOR complex 1 (mTORC1) or mTOR complex 2 (mTORC2). While these complexes share several key protein components, unique differences in their complex composition dramatically alter the function and downstream cellular targets of mTOR activity. While significant work has gone into analysis of molecular alterations of the mTOR pathway in bladder cancer, this has not yielded significant benefit in mTOR-targeted therapy approaches in urothelial carcinoma to date. New discoveries regarding signaling convergence onto mTOR complexes in bladder cancer could yield unique insights the biology and targeting of this aggressive disease. In this review, we highlight the functional significance of mTOR signaling in urothelial carcinoma and its potential impact on future therapy implications.
    Language English
    Publishing date 2022-03-18
    Publishing country Switzerland
    Document type Journal Article ; Review
    ZDB-ID 2527080-1
    ISSN 2072-6694
    ISSN 2072-6694
    DOI 10.3390/cancers14061555
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  9. Article ; Online: Editorial comment.

    Hansel, Donna E

    The Journal of urology

    2013  Volume 189, Issue 5, Page(s) 1660–1661

    MeSH term(s) Carcinoma, Transitional Cell/drug therapy ; Carcinoma, Transitional Cell/secondary ; Female ; Humans ; Male ; Peritoneal Neoplasms/secondary ; Urinary Bladder Neoplasms/drug therapy ; Urinary Bladder Neoplasms/pathology
    Language English
    Publishing date 2013-02-16
    Publishing country United States
    Document type Journal Article ; Comment
    ZDB-ID 3176-8
    ISSN 1527-3792 ; 0022-5347
    ISSN (online) 1527-3792
    ISSN 0022-5347
    DOI 10.1016/j.juro.2012.11.194
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  10. Article ; Online: MRI appearance of BRCA-associated prostate cancer.

    Kamal, Omar / Foster, Bryan R / Young, Daniel J / Hansel, Donna E / Coakley, Fergus V

    Clinical imaging

    2022  Volume 84, Page(s) 135–139

    Abstract: Despite advances in diagnosis and treatment, prostate cancer remains the second leading cause of cancer related mortality in men. Prognosis is variable and dependent on several clinical and genetic factors, including BRCA gene mutations. Recent clinical ... ...

    Abstract Despite advances in diagnosis and treatment, prostate cancer remains the second leading cause of cancer related mortality in men. Prognosis is variable and dependent on several clinical and genetic factors, including BRCA gene mutations. Recent clinical studies have reported that BRCA-associated prostate cancer is a more aggressive subtype with a higher probability of nodal involvement and distant metastases at the time of diagnosis, but radiological findings have not been described. Accurate recognition of those tumors could help guide clinical management and prompt testing and counseling for BRCA mutations. We have recently encountered four patients with BRCA-associated prostate cancer who underwent multiparametric MRI. The MRI appearances of these tumors, which were generally locally advanced and aggressive in appearance, are presented to facilitate recognition of BRCA-associated prostate cancer and guide potential genetic testing and counseling.
    MeSH term(s) Humans ; Magnetic Resonance Imaging ; Male ; Mutation ; Prognosis ; Prostatic Neoplasms/diagnostic imaging ; Prostatic Neoplasms/genetics ; Prostatic Neoplasms/pathology
    Language English
    Publishing date 2022-02-19
    Publishing country United States
    Document type Journal Article
    ZDB-ID 1028123-x
    ISSN 1873-4499 ; 0899-7071
    ISSN (online) 1873-4499
    ISSN 0899-7071
    DOI 10.1016/j.clinimag.2022.02.007
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

To top